Audited Financial Results for the quarter and Year ended on 31st March 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.2 pts less than Nifty Microcap 250 and 3.2 pts less than its Other Financial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Relic Technologies reported widening losses for FY25, with standalone net loss nearly doubling to ₹171.87 lakhs from ₹89.24 lakhs in FY24, on revenue of ₹166.32 lakhs (vs ₹153.31 lakhs). Q4 FY25 was particularly weak with standalone revenue crashing to ₹15.50 lakhs from ₹38.20 lakhs in Q4 FY24. Total expenses surged to ₹346.49 lakhs (from ₹253.10 lakhs), driven mainly by higher other expenses and employee costs. On a consolidated basis (including newly acquired Truhealthy Wellness, acquired in March 2025), net loss was ₹148.74 lakhs on revenue of ₹197.59 lakhs, with ₹232.12 lakhs of goodwill on consolidation. Operating cash flow was negative at ₹(36.64) lakhs consolidated and ₹(203.67) lakhs standalone, though cash balance rose sharply to ₹709.79 lakhs due to ₹622.19 lakhs in share application money from a preferential issue of 15.5 lakh shares at ₹85 each.
Persistent and widening losses, negative operating cash flows, and a sharp Q4 revenue decline point to continued pressure on core operations. However, the company has raised fresh capital via a preferential share issue and completed a subsidiary acquisition, which bolsters the balance sheet but does not address the underlying profitability concerns. Shareholders should view this as a loss-making company in transition, not a turnaround yet.